Analyst Reco. Intensity Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
4 ^USD	+6.38%		+3.63%	-53.33%

05-10	Intensity Therapeutics Collaborates With Swiss Group on Clinical Research for Breast Cancer Trial	MT
05-10	Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate	CI